BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 11867015)

  • 21. Fulminant varicella hepatitis in a human immunodeficiency virus infected patient: case report and review of the literature.
    Lechiche C; Le Moing V; François Perrigault P; Reynes J
    Scand J Infect Dis; 2006; 38(10):929-31. PubMed ID: 17008242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of herpes simplex and varicella zoster infections in patients of HIV infections].
    Caumes E; Bricaire F
    Ann Med Interne (Paris); 1997; 148(3):255-7. PubMed ID: 9255335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiviral drug therapy of infections caused by Herpes simplex and Varicella Zoster viruses].
    Vogt M; Huss R; Wunderli W
    Schweiz Med Wochenschr; 1992 Apr; 122(16):569-75. PubMed ID: 1579862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis, chickenpox and scabies outbreaks in an orphanage for children with HIV/AIDS in Jamaica.
    Geoghagen M; Pierre R; Evans-Gilbert T; Rodriguez B; Christie CD
    West Indian Med J; 2004 Oct; 53(5):346-51. PubMed ID: 15675502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome.
    Meenken C; van den Horn GJ; de Smet MD; van der Meer JT
    Ann Neurol; 1998 Apr; 43(4):534-6. PubMed ID: 9546338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
    Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
    Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
    Armenian SH; Han JY; Dunaway TM; Church JA
    Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella vaccination in children after bone marrow transplantation.
    Sauerbrei A; Prager J; Hengst U; Zintl F; Wutzler P
    Bone Marrow Transplant; 1997 Sep; 20(5):381-3. PubMed ID: 9339753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the varicella vaccine in immunocompromised individuals.
    Sartori AM
    Int J Infect Dis; 2004 Sep; 8(5):259-70. PubMed ID: 15325594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Varicella-associated morbidity in children undergoing chemotherapy for acute lymphoblastic leukaemia].
    Sørensen GV; Helgestad J; Rosthøj S
    Ugeskr Laeger; 2009 Nov; 171(46):3354-9. PubMed ID: 19925741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
    Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
    Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children.
    Krause PR; Klinman DM
    Nat Med; 2000 Apr; 6(4):451-4. PubMed ID: 10742154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.